Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials
Disitamab Vedotin治疗人表皮生长因子受体2阳性局部晚期或转移性尿路上皮癌患者的疗效和安全性:两项II期临床试验的联合分析
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.22.02912
Sheng, Xinan; Wang, Lin; He, Zhisong; Shi, Yanxia; Luo, Hong; Han, Weiqing; Yao, Xin; Shi, Benkang; Liu, Jiyan; Hu, Changlu; Liu, Ziling; Guo, Hongqian; Yu, Guohua; Ji, Zhigang; Ying, Jianming; Ling, Yun; Yu, Shiying; Hu, Yi; Guo, Jianming; Fang, Jianmin; Zhou, Aiping; Guo, Jun